Fridays vs LillyDirect (Zepbound) (2026): prices, structure, verdict

On tirzepatide, Fridays is cheaper: $359 versus $449 a month all-in — a $90 monthly gap, $1,080 across a year of maintenance dosing, and Fridays's figure is dose-flat while LillyDirect (Zepbound)↗'s structure is not.

Updated 2026-08-10 · figures captured 2026-08-09 · how we verify

On semaglutide, only Fridays has a rankable figure: $175 a month all-in; LillyDirect (Zepbound) does not offer semaglutide.

§ Side by side

§ Each record, read aloud

The two records, condensed

Fridays: the record, condensed

On tirzepatide, the number that matters at Fridays is $359 a month all-in — the figure at the 10 mg maintenance basis this whole site ranks on. The price is dose-flat: the standard titration ladder (2.5 → 5 → 7.5 → 10 mg (12.5 and 15 mg available)) is financially invisible here, because the top rung bills exactly what the bottom rung billed. That converts the advertised number from a floor into a ceiling — the strongest single structural feature a program in this category can have.

The absence worth noticing: no mandatory membership. Across this index memberships run $25–$145 a month and hide outside headline prices; here the headline is the bill.

To place the number: #13 of 17 verified programs, with the floor $144/month below at NexLife↗ ($215); the approved-product yardstick (Zepbound (LillyDirect)) sits at $449, so the compounded case here is worth $90 a month. A year at this figure: $4,308 monthly-billed.

Start with the load-bearing figure: $175 a month, all-in, is what Fridays charges for semaglutide at the 2.4 mg basis. The price is dose-flat: the standard titration ladder (0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg) is financially invisible here, because the top rung bills exactly what the bottom rung billed. That converts the advertised number from a floor into a ceiling — the strongest single structural feature a program in this category can have.

There is no membership line. $175 is the billed total — consultation and clinical review are inside it, and no platform fee recurs beside it, which removes the most common way advertised GLP-1 prices understate billed ones.

Context for that figure: it ranks #7 of 20 in the verified semaglutide index — $42/month above the floor (Oak Longevity, $133) — and sits $174 under the brand benchmark (Wegovy (NovoCare↗), $349 at maintenance). Annualized, a monthly-billed year here runs $2,100.

Operationally at Fridays: shipping included; commitment annual plan for lowest rate; cancellation not published; pharmacy not publicly named — ask in writing before paying; states: not published; evidence third-party reported, captured 2026-08-05. The full record with source and archive links: the Fridays page · visit Fridays ↗

LillyDirect (Zepbound): the record, condensed

On tirzepatide, the number that matters at LillyDirect (Zepbound) is $449 a month all-in — the figure at the 10 mg maintenance basis this whole site ranks on. Note the shape: $299 is the number in the marketing, $449 is the number at maintenance. The $150 difference is not a fee or a trick per se — it is dose-tiered pricing doing what dose-tiered pricing does — but it means the advertised figure describes month one, not month twelve.

There is no membership line. $449 is the billed total — consultation and clinical review are inside it, and no platform fee recurs beside it, which removes the most common way advertised GLP-1 prices understate billed ones.

To place the number: #0 of 17 verified programs, with the floor $234/month below at NexLife ($215); the approved-product yardstick (Zepbound (LillyDirect)) sits at $449, so the compounded case here is worth nothing a month — at which point brand deserves the first look. A year at this figure: $5,388 monthly-billed.

Operationally at LillyDirect (Zepbound): shipping included (or same-day retail pickup); commitment 45-day refill cadence to keep pricing; cancellation no subscription; refill-window rules apply; pharmacy named (Eli Lilly direct / retail partners); states: 50 states; evidence source-verified, captured 2026-08-09. The full record with source and archive links: the LillyDirect (Zepbound) page · visit LillyDirect (Zepbound) ↗

Tirzepatide: the duel in full

Put the two tirzepatide figures side by side and hold them there: Fridays at $359, LillyDirect (Zepbound) at $449 — a $90 monthly spread that compounds to $1,080 over a maintenance year and $2,160 over two.

Structure sharpens the gap: Fridays’s figure is dose-flat (2.5 → 5 → 7.5 → 10 mg (12.5 and 15 mg available) all bill the same), while LillyDirect (Zepbound)’s is not — so Fridays’s number is a ceiling and LillyDirect (Zepbound)’s advertised entry ($299) is a floor. Comparing a ceiling to a floor flatters the floor; this site compares maintenance to maintenance, which is the table above.

A way to feel the $90 monthly gap: over a year it funds 3.0 extra months at Fridays’s own rate — the difference is not decoration, it is medication. Over two years it compounds to $2,160, which is the horizon at which structural details (prepaid ladders, membership drag, dose-tier repricing) start mattering more than the sticker itself.

Run the same two programs on the committed basis: Fridays $359/mo month-to-month against LillyDirect (Zepbound) $449/mo month-to-month. The order holds: Fridays leads on both readings, so plan structure sharpens the verdict here rather than reversing it. Whichever basis fits your commitment level, the upfront totals above are the honest units.

§ The clock, run forward

Three, six, twelve, twenty-four months — best path each way

3 months: Fridays $1,077 monthly; LillyDirect (Zepbound) $1,347 monthly — best path favors Fridays by $270. 6 months: Fridays $2,154 monthly; LillyDirect (Zepbound) $2,694 monthly — best path favors Fridays by $540. 12 months: Fridays $4,308 monthly; LillyDirect (Zepbound) $5,388 monthly — best path favors Fridays by $1,080. 24 months: Fridays $8,616 monthly; LillyDirect (Zepbound) $10,776 monthly — best path favors Fridays by $2,160.

Prepaid paths above are billed upfront and assume the published rate holds (the 24-month figures extend the 12-month rate, an assumption worth naming). The honest reading: over short horizons the monthly gap decides; over long horizons the prepaid ladders and structural traps (dose tiers, memberships) take over — which is exactly the split the verdict section below scores.

§ Structure vs structure

Everything besides the price

Coverage: Fridays publishes “not published”; LillyDirect (Zepbound) publishes “50 states” — for anything short of an explicit 50-state claim, intake is the final word.

Pharmacy transparency splits them: LillyDirect (Zepbound) names its network (Eli Lilly direct / retail partners); Fridays does not, which shifts the burden of verification onto your intake questions.

Exit terms: Fridays — annual plan for lowest rate; not published. LillyDirect (Zepbound) — 45-day refill cadence to keep pricing; no subscription; refill-window rules apply.

Evidence: Fridays third-party reported (captured 2026-08-05); LillyDirect (Zepbound) source-verified (2026-08-09).

The pattern worth internalizing: in this market, structural honesty and price honesty travel together. Programs that publish pharmacies and state lists tend to publish real maintenance prices; programs that hide one usually hide the other.

§ If you move

Switching between Fridays and LillyDirect (Zepbound)

Prescriptions do not transfer like phone numbers: moving in either direction means completing the destination’s intake and having its prescriber write a new patient-specific prescription. The mechanics that prevent a bad month: confirm the destination serves your state and quotes your current dose in writing before cancelling anything; time the first new shipment to overlap the last old one rather than gap it; cancel the origin per its published terms (Fridays: not published; LillyDirect (Zepbound): no subscription; refill-window rules apply) and screenshot the confirmation; and never leave a prepaid balance stranded — which is the standing argument for prepaying only after a program has already earned a few monthly cycles.

§ Verdict by situation

Which one, for whom

§ More pairings